Studies using the prestin knockout mouse indicate that removal of the outer hair cell (OHC) motor protein is associated with loss of sensitivity, frequency selectivity and somatic electromotility. Here we provide data obtained from another prestin mouse model that was produced commercially. In vivo electrical recordings from the round window indicate that the phenotype is similar to that of the original knockout generated by the Zuo group at St. Jude Children’s Research Hospital. Hence, compound action potential (CAP) thresholds are shifted in a frequency-dependent manner and CAP tuning curves at 12 kHz are flat for masker frequencies between 3 and 18 kHz. Although CAP input-output functions at 6 kHz show a shift in sensitivity at low levels, responses approach wild-type magnitudes at high levels where the cochlear amplifier has less influence. In order to confirm that the loss of sensitivity and frequency selectivity is due to loss of prestin, we performed immunohistochemistry using a prestin antibody. Cochlear segments from homozygous mutant mice showed no fluorescence, while wild-type mice displayed a fluorescent signal targeted to the OHC’s lateral membrane. Absence of prestin protein was confirmed using LDS-PAGE/Western blot analysis. These results indicate that the loss of function phenotype is associated with loss of prestin protein. Lack of prestin protein also results in a shortening of OHC length to ∼60% of wild-type, similar to that reported previously by Liberman’s group. The linkage shown between the loss of prestin protein and abnormal cochlear function validates the original knockout and attests to the importance of OHC motor function in the auditory periphery.

Keywords:
Mouse cochlea, Compound action potential, Outer hair cells, Prestin
1.
Bohne BA: Location of small cochlear lesions by phase contrast microscopy prior to thin sectioning. Laryngoscope 1972;82:1–16.
2.
Bohne BA, Harding GW: Processing and analyzing the mouse temporal bone to identify gross, cellular and subcellular pathology. Hear Res 1997;109:34–45.
3.
Bohne BA, Harding GW, Ou HC: Preparation and evaluation of the mouse temporal bone; in Willott, JF (eds): Handbook of Mouse Auditory Research: From Behavior to Molecular Biology. Boca Raton, CRC Press, 2001, pp 171–187.
4.
Brown MC, Smith DI, Nuttall AL: The temperature dependency of neural and hair cell responses evoked by high frequencies. J Acoust Soc Am 1983;73:1662–1670.
5.
Cheatham MA, Huynh KH, Gao J, Zuo J, Dallos P: Cochlear function in prestin knockout mice. J Physiol 2004;560:821–830.
6.
Cheatham MA, Zheng J, Huynh KH, Du GG, Gao J, Zuo J, Navarrete E, Dallos P: Cochlear function in mice with only one copy of the prestin gene. J Physiol 2005;569:229–241.
7.
Dallos P, Cheatham MA: Compound action potential (AP) tuning curves. J Acoust Soc Am 1976;59:591–597.
8.
Dallos P, Schoeny ZG, Worthington DW, Cheatham MA: Cochlear distortion: effect of direct-current polarization. Science 1969;164:449–451.
9.
Gummer AW, Smolders JW, Klinke R: Basilar membrane motion in the pigeon measured with the Mössbauer technique. Hear Res 1987:29:63–92.
10.
Jaramillo F, Markin VS, Hudspeth AJ: Auditory illusions and the single hair cell. Nature 1993;364:527–529.
11.
Liberman MC, Gao J, He DZ, Wu X, Jia S, Zuo J: Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier. Nature 2002;419:300–304.
12.
Liberman MC, Zuo J, Guinan JJ Jr: Otoacoustic emissions without somatic motility: can stereocilia mechanics drive the mammalian cochlea? J Acoust Soc Am 2004;116:1649–1655.
13.
Matsuda K, Zheng J, Du GG, Klocker N, Madison LD, Dallos P: N-linked glycosylation sites of the motor protein prestin: effects on membrane targeting and electrophysiological function. J Neurochem 2004;89:928–938.
14.
Muller M, von Hunerbein K, Hoidis S, Smolders JW: A physiological place-frequency map of the cochlea in the CBA/J mouse. Hear Res 2005;202:63–73.
15.
Ohlemiller KK, Siegel JH: The effects of moderate cooling on gross cochlear potentials in the gerbil: basal and apical differences. Hear Res 1992;63:79–89.
16.
Özdamar O, Dallos P: Input-output functions of cochlear whole-nerve action potentials: interpretation in terms of one population of neurons. J Acoust Soc Am 1976;59:143–147.
17.
Patuzzi RB, Yates GK, Johnstone BM: Outer hair cell receptor current and sensorineural hearing loss. Hear Res 1989;42:47–72.
18.
Pearce M, Richter CP, Cheatham MA: A reconsideration of sound calibration in the mouse. J Neurosci Methods 2001;106:57–67.
19.
Safieddine S, Wenthold RJ: The glutamate receptor subunit delta1 is highly expressed in hair cells of the auditory and vestibular systems. J Neurosci 1997;17:7523–7531.
20.
Shore SE, Nuttall AL: The effects of cochlear hypothermia on compound action potential tuning. J Acoust Soc Am 1985;77:590–598.
21.
Taylor MM, Creelman CD: PEST: efficient estimates on probability functions. J Acoust Soc Am 1967;41:782–787.
22.
Thomas KR, Capecchi MR: Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987;51:503–512.
23.
Wu X, Gao J, Guo Y, Zuo J: Hearing threshold elevation precedes hair-cell loss in prestin knockout mice. Brain Res Mol Brain Res 2004;126:30–37.
24.
Zheng QY, Johnson KR, Erway LC: Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 1999;130:94–107.
25.
Zheng J, Shen W, He DZ, Long KB, Madison LD, Dallos P: Prestin is the motor protein of cochlear outer hair cells. Nature 2000;405:149–155.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.